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ABSTRACT 
 
A causal interaction between nutrition and the outcome of different infections has been known 
since long time ago. Moreover, responses of human beings to infection are diverse and 
demarcated by immunity. A deficient and unappropriated nutrition allows to a deficient 
immune response. The dynamic interconnection between nutrition, immunity and the outcome 
of infection creates a cycle. If one of these states is altered, the proper balance of a healthy 
system will varnish. The purpose of this thesis is to introduce studies that reflect this interaction 
by exploring both, epidemiological and experimental settings. 
The first cross-sectional, epidemiological study showed a considerable prevalence of 
overweight and obesity in school children from Caranavi, a community that represented the 
Bolivian Lowlands.  As for the Highlands, Taraco community remained opposite, with higher 
prevalence of undernourishment and even stunting, while overweight and obesity were not that 
prevalent. Remarkably, anemia was found highly prevalent in children from Taraco, compared 
to lower numbers in Caranavi. More than half of both populations showed vitamin D 
insufficiency. This study showed increased anaemia, nutritional deficiencies, and indications 
of poor hygienic conditions in highlands compared with lowlands.  
Intestinal nematodes modulate immune responses in the context of secondary infection and 
vaccination. Several mechanisms have been proposed for a possible suppressive effect. In the 
second study, it was shown that chronic nematode infection leads to reduced peripheral 
responses to vaccination because of a generalized reduction in the available responsive 
lymphocyte pool. In detail, it was shown that superficial skin-draining lymph nodes (LNs) in 
infected mice with the intestinal nematode Heligmosomoides polygyrus, have an altered 
lymphocyte composition and less cellularity than uninfected mice upon subsequent BCG 
infection in the skin. Moreover, B cells and T cells were also lower in skin draining LN. 
Notably, de-worming and time improved lymphocyte cellularity in LNs and restored Bacillus 
Calmette-Guerin (BCG) responses in the draining LN of the footpad injection site, concluding 
that chronic nematode infection leads to a paucity of lymphocytes in distal lymph nodes that 
reduces the efficacy of peripheral immune responses.  
Obesity can lead to diabetes. Moreover, diabetes increases the risk of developing tuberculosis 
(TB), but the underlying mechanisms in the tuberculosis-diabetes (TB-DM) co-morbidity are 
not well defined. This study analyzed the susceptibility to Mycobaterium tuberculosis (Mtb) in 
a diabetic mice model and focused in the role of HIF-1α, a main regulator of metabolic and 
inflammatory responses, in the outcome of Mtb infection under hyperglycemia and diabetic 
models. It was observed that mycobacterial infection of macrophages (BMM) or mice 
increased the expression of HIF-1α-regulated glut1 and vegfa genes. Interestingly, incubation 
of BMM with deferoxamine (DFO), a HIF-1α stabilizer, increased levels of HIF-1α-regulated 
immune and metabolic transcripts in both mycobacteria-infected and uninfected BMM. 
Moreover, M. tuberculosis load was reduced in DFO-incubated BMM. Hyperglycemic 
conditions reduced the expression of glut1, vegfa, inos and il1b mRNA in mycobacteria 
infected BMM and DFO treatment reversed this effect. In line with this, M. tuberculosis levels 
were higher, and HIF-1α - responses reduced in lungs from db/db mice.  DFO-treated mice had 
increased levels of HIF-1α-regulated transcripts in infected organs, and reduced M. 
tuberculosis load in lungs. These findings suggest that an increase of HIF-1α function can 
improve the control of infection with M. tuberculosis during DM. 
Altogether, these studies, although diverse, support the importance of the link between 
nutrition, immune responses and the outcome of two different infections.  
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  1 
 INTRODUCTION 
1.1     NUTRITION AND HEALTH 
Nutrition is the set of integrated processes by which cells, organs and the whole body acquire 
the energy and nutrients for normal structure and function. It also relates to the capacity of the 
body to transform the substrates and cofactors necessary for metabolism. Life-maintaining 
chemical reactions, result in the build-up of proteins, lipids, nucleic acids and carbohydrates 1. 
In simpler words, the World Health Organization (WHO) defines nutrition as the intake of food 
considered in relation to the body’s dietary needs 2. 
A balanced nutritional state responds to tightly associated external and internal factors. 
Externally, it is related to the environment and society, for example, the quality of consumed 
food. The internal factors are mostly related with the functioning of cells, organs and tissues 
through chemical, physiological and metabolic mechanisms 3. The control and maintenance of 
good nutrition in the world population has always been of special concern, mainly because of 
the negative consequences its absence has for global health.  
1.1.1. Malnutrition: Under- and Overweight 
The term malnutrition reflects an excess or imbalance of a wide range of nutrients, resulting in 
a measurable adverse effect on body composition, function and clinical outcome. There is still 
a misleading use of malnourished as undernourished only. However, when referring to 
malnourished individuals, it is important to be aware that they can be under- or over-nourished.  
Malnutrition is responsible for more ill health among people than any other cause 4. Most forms 
of malnutrition are associated with different types of diseases and higher levels of mortality in 
comparison to the same diseases seen in well-nourished patients. The WHO exposes alarming 
numbers regarding the actual nutritional state nowadays. Around 1.9 billion adults are 
overweight or obese, while 462 million are underweight, 52 million children under 5 years of 
age are wasted, 17 million are severely wasted and 155 million are stunted, while 41 million 
are overweight or obese (definition of nutritional states farther down). Mortality is still a 
significant consequence of this nutritional imbalance, and around 45% of deaths among 
children under 5 years of age are linked to malnourishment. These deaths mostly occur in low- 
and middle-income countries. At the same time, in these same countries, rates of childhood 
overweight and obesity are rising 5. The combination of these two extremes of malnutrition in 
a same place is known as the double-burden effect. 
There are several factors that play a role to define a nutritional status in a certain population. 
For instance, access to water, sanitation and hygiene linked to education and incomes are all 
essential. Moreover, the quality of diets is vital. Poor diets are the second-leading risk factor 
for deaths globally, accounting for 18.8% of all deaths, of which 50% are due to cardiovascular 
disease 6. Both overweight and underweight severely affect immune functions severely, leading 
to an increased susceptibility to severe infections. Undernutrition and overweight/obesity are 
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two broad groups that include more specific malnutrition subcategories. The classification 
below is adapted from The Global Nutrition Report 2018 - UNICEF 4. 
Undernutrition 
It is important to consider the age when classifying undernutrition, because all children under 
five years are in an important and intensive process of growing, learning and developing brain 
skills.  
i. Stunting in children under five: Refers to a form of growth failure which 
starts already in prenatal stages and develops over a long period of time 
in children under five years of age with limited access to food, health 
and care. Stunting is also known as ‘chronic undernutrition’, although 
this is only one of its causes. Stunting is associated with, and often 
causes cognitive impairments such as delayed motor development, 
impaired brain function and poor school performance. 
ii. Wasting in children under five: Children who are thin for their height 
because of acute food shortages or disease. Also known as ‘acute 
malnutrition’, wasting means a rapid deterioration in nutritional status 
over a short period of time in children under five years of age. The risk 
of dying is higher in these children. Compared to stunting, wasting 
children might be heavily underweight but their height is similar as 
compared to median of a population that has no shortage in nutrition. 
iii. Underweight in the population that is more than five years old is usually 
measured by body mass index (BMI), a simple index of weight-for-
height (weight in kg/height in m2). If the BMI is less than 18.5 indicates 
underweight in adult populations while a BMI less than 17.0 indicates 
moderate to severe thinness. A BMI less than 16.0 is known to be 
associated with a markedly increased risk for ill health, poor physical 
performance, lethargy and even death; this cut-off point is therefore a 
valid extreme limit. 
iv. Micronutrient deficiencies: Undernutrition also includes an important 
group of people with micronutrient deficiencies. This stands for a poor 
nutritional status caused by a lack of intake, absorption or use of one or 
more vitamins or minerals needed for essential physiological functions, 
growth and development. Several micronutrients that remain issues 
globally include iron, zinc, vitamin A, D, folate and iodine, as they are 
the most difficult to satisfy without diverse diets. One general indicator 
of micronutrient deficiencies is anemia, as this syndrome is caused by 
the deficiency of many of them, and its effects are exacerbated by 
several diseases  
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Overweight and Obesity 
An abnormal or excessive accumulation of body fat impairs health. Overweight and obesity 
can also be measured by BMI. In adults, overweight is defined as a BMI of 25 or more, whereas 
obesity is a BMI of 30 or more 7. In children, BMI is adjusted to age to measure malnutrition. 
In this line, the BMI/age indicator is the most accurate anthropometric measurement for 
children. Overweight and obesity cause morbidity and mortality through multiple effects on 
nearly all human functions and are major causes of many non-communicable diseases (NCDs), 
including non-insulin-dependent diabetes mellitus, coronary heart disease and stroke. They 
also increase the risks for several types of cancer, gallbladder disease, musculoskeletal 
disorders, respiratory symptoms and the susceptibility to several infections 8 . 
1.1.2. Nutrition and Infections/Immunity 
Malnutrition has a clear but, in many cases, not well-defined role in the regulation of immune 
responses. The association of nutritional status with the risk and course of infections, and the 
nutrition during infection are important topics of research nowadays. Experimental and pre-
clinical studies highlighted the changes in pathogen-host interactions under malnutrition and 
have also elucidated how these alterations impact the host’s antimicrobial immune functions, 
the resistance to infection as well as the pathogen’s proliferation and pathogenicity 9. 
Regarding the influence of nutrition on the risk of infections, the focus has frequently been on 
underweight conditions rather than on obesity. There is an association between anthropometric 
parameters of undernourishment and higher severity of infections. For instance, viral diseases 
as influenza and RSV, bacterial infections as tuberculosis (TB) and colonization by 
Streptococcus and parasites including Schistosomiasis and Amebiasis have all been associated 
with undernourishment at the population levels 10.  Nutritional intervention has been performed 
clinically in TB patients, but the improvement evidence is still weak 11. Cross-sectional 
community surveys revealed increased prevalence of intestinal parasitic infections in children 
between 6 months to 15 years with low BMI 12. Moreover, a prospective study showed stunned 
children aged 6 weeks to 1 year and HIV-infected with an increased incidence of malaria 
infection 13.   
Underweight children are not only at higher infection risk in developing countries. In USA, a 
clinical-chart review revealed that underweight children were more frequently admitted to 
emergency units with respiratory infections than normal-weight, overweight or obese children 
14. With an increase understanding of severe childhood malnutrition and the role of oxidative 
stress, the primary role formerly ascribed to protein deficiency is no longer accurate, neither 
concerning the condition in general, nor to the impact of malnutrition on susceptibility to 
infections 15. Moreover, the insufficient intake of carbohydrates and lipids has an important 
effect on innate immune responses. For instance, dietary restriction resulted in reduced 
neutrophil trafficking to sites of inflammation, due to a reduction in integrin expression and 
chemokine production 16. Moreover, the necessity of glucose and glutamine in macrophages 
and neutrophils is evident, they rely on a withdrawal of these to metabolize and produce 
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cytokines and phagocytosis. Moreover, certain fatty acids also modulate macrophage and 
neutrophil resources 17, 18. 
When it comes to obesity, less evidence of its impact on the immune system is found. Obesity 
has been linked with increased incidence of infectious diseases, including periodontal 
infections, influenza, bacterial pneumonia, nosocomial and surgical site infections 19,20.  In 
a cross-sectional study performed in a Dutch birth cohort, obesity in 8-year-old children was 
associated with more than 5-fold increased bronchitis rates and also raised use of antibiotics 21. 
Similarly, in an inpatient US database of participants aged 2–20 years the risk of urinary tract 
infections was increased in obese females but not in obese males. Obesity was defined by >95th 
percentile of weight in this study 22. 
Several mechanisms involved in the increased susceptibility to infections during obesity have 
been suggested. For instance, susceptibility to infections in obesity might be related to 
decreased availability of arginine and glutamine, resulting in decreased tumor necrosis factor 
(TNFα) production, as shown in obese rats 23. Moreover, another experimental model showed 
that obese mice exhibited an exaggerated proinflammatory and thrombogenic responses under 
the same stimuli as control mice. The connection of proinflammatory states of obesity with the 
risk of infection has not been precisely determined, but leptin seems to have an important role 
in the immune response. Leptin deficiency has been associated with susceptibility to infections 
in animals as well as in human beings 24.  
1.1.3. Nutrition in Children from Bolivia: Situation in High and Lowlands 
Latin America and the Caribbean are still regions where hunger and malnourishment are an 
important health problem. The best way to address this scourge is by linking food security, 
sustainability, agriculture and health. Around 5.5% of the regional population are still 
undernourished, and 11.3% of children under 5 years old face stunting while 7.2% are 
overweight 25. 
Bolivia is one of the most poorly developed Latin American countries and has the highest 
prevalence of undernutrition among the Andes. Data from 2009 states that 27% of children are 
stunted, 14% are underweight and 3% are wasted  26. Due to the influence of globalization, 
Bolivia is now in a nutritional transition; because of that the local food consumption is 
competing with the incorporation of “junk food” that is usually high in calories from sugar or 
fat, with little dietary fiber, protein, vitamins or minerals. There is limited knowledge regarding 
the actual situation of nutritional status in children that live in small districts in Bolivia, but, it 
is known, that rural areas from highlands have limited availability of nutrients because of the 
environmental conditions, where some foods like vegetables and others are hard to grow, while 
this is not the case in the Lowlands. 
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Highlands 
One-third of Bolivia is located within the Andean mountain range. The altiplanic highlands are 
known for their fragile ecosystem and high poverty level. Altitude reaches more than 4000 
masl (meters above sea level), and only few areas in the world develop agriculture in this harsh 
environment. Altogether, this explains why the nutritional intake in Bolivian highlands is lower 
than in the tropical valleys. Previous studies mentioned the frequent use of potatoes and other 
tubers as well as some crops as quinoa in the Andean diet. A systematic review made in 
different Andean highlands of Latin America including Bolivia, showed a low average intake 
of dietary fat, iron, zinc, calcium, vitamin A, folate and vitamin B12 27. A study that measured 
the dietary quality index based on FAO standards showed that children´s diet were adequate 
for all nutrients except calories, calcium, niacin and thiamin. Low oxygen pressure in the 
highlands also plays an important role, recumbent length gain was found to be slower in high 
altitude infants in the early months of life compared to children from the lowlands. Children 
who had lived all their lives at high altitude were found to be smaller in terms of general body 
size than those who had spent the shortest amount of time at high altitude 28. Currently, only 
few studies have focused in children nutritional status in the Bolivian highlands. 
Lowlands 
The term “Lowlands” is extensive and conforms several regions in Bolivia, where sub-tropical 
valleys at 600 to 800 masl are also included. Due to less harsh conditions that allow agriculture 
and cattle farming to establish, nutrients are much more diverse and easily available. A variety 
of local fruits and vegetables is accessible for the population, and the intake of meat, chicken 
and fish is more frequent. These conditions are of considerable help to improve children´s 
growth when compared to highlands. Although topographic conditions, like altitude, are 
important for growth development in children, other socioeconomic factors must also be 
considered. Socio-economic and urban development go together in children´s health and 
growth. This comprises the changes of traditional habits of food consumption and education.  
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1.2. INTESTINAL NEMATODE INFECTIONS AND IMMUNITY 
Parasitic worm infections are prevalent in many developing countries where hygienic 
conditions are poor and rudimentary. This situation facilitates the maintenance of parasite-cycle 
and the risk constant re-infections of individuals.  
It has been estimated that one of fifth of all humans are hosting one or more species of 
gastrointestinal nematodes 29. The 2016 Global Burden of Disease study indicated that 
currently 800 million of individuals are likely to be infected worldwide with A. lumbricoides, 
451 million with hookworm, 435 million with Tricuriasis and 190 million with Schistosomiasis 
30. The health impact of intestinal nematode infections is the significant morbidity that they 
cause, because they barely produce severe pathology or mortality. Infected people, mostly 
children, will show symptoms ranging from different intensities of abdominal pain, diarrhea, 
mild to moderate anemia, and long term stunned growth with impaired cognitive development. 
In most endemic areas, the presence of helminth co-infection with diseases like TB and HIV 
are of concern. They cause a significant host resistance reduction to the infecting as well as 
other microorganisms causing diseases. Moreover, helminth infections have been found to 
affect vaccine efficacy and impair  immune responses to vaccines against TB and tetanus 31. 
However, some intestinal parasitic infections may come with benefits. For instance, an 
excessive cleanliness could alter the balance of the immune system without any parasite 
exposure, resulting in reactions to harmless environmental molecules, food antigens and others. 
In animal models, immunological disorders like asthma, allergy or inflammatory bowel disease 
have all found to be reduced in the presence of intestinal worm infections 32. In humans, this 
theory has gained some support from epidemiological studies. This inverse correlation between 
intestinal microorganisms and immune-mediated diseases is known as the hygiene hypothesis 
33. 
1.2.1. Heligmosomoides polygyrus Infection: A Model of Murine 
Helminthiasis   
Heligmosomoides polygyrus (Hp) is a natural intestinal parasite of mice. This parasite was first 
introduced in the lab by Spurlock in 1943 as an experimental infection in laboratory mice 34 . 
Nowadays, H. polygyrus is the most widely used model to study the impact of gastrointestinal 
nematode infection for immunological, toxicological and pharmacological studies. There are 
several characteristics that make this worm a very useful and efficient model. The infection is 
limited to the intestines and can be established and maintained as a chronic infection. The 
pathology and morbidity caused by the worm, even using high doses of larvae, is limited 
making H. polygyrus suitable for studying trace susceptibility as well as resistance to intestinal 
worm infection over time and in combination with other pathologies and infections.  
The life cycle of H. polygyrus starts with a brief histotrophic larval phase in the intestinal 
mucosa around 24 h after oral gavaging of mice with infective L3 larvae. Usually a strong 
inflammatory response and the formation of a structure called “granulomata” at the site of 
encystment takes place during this phase. These granulomas mainly consist of macrophages 
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and neutrophils, but the number and frequency of granulomas depends on the resistance 
phenotype of mouse strains, the most resistant genotypes will develop greater granuloma 
numbers 35.  Around 10 days later, a longer adult luminal phase will take place in the proximal 
third of the small intestine. The adult worms twirl around the small intestine villi to secure 
themselves, to mate and start eggs production. The eggs hatch and undergo two molts to 
become infective stage 3 Larvae (L3s) to continue the life cycle 36.  
1.2.2 Immune Responses to Intestinal Nematodes: Heligmosomoides 
polygyrus: Th2/Regulatory Responses 
Helminths are successful organisms. They develop chronic infections that without therapeutic 
intervention can last a lifetime in the host. In this parasite-host interaction, an active 
immunomodulation takes place, creating frequently a muted immune response in which the 
host adapts and tolerates the invader. 
Innate immune responses are initiated by danger signals. Intestinal helminths introduce 
damaged-associated molecular patterns DAMPS and pathogen-associated molecular patterns 
PAMPS which elicit surface interactions. The activation of epithelial release cytokines like 
thymic stromal lymphopoietin (TSLP), IL-25 and IL-33 37. These cytokines promote the 
proliferation of innate lymphoid cells type 2 (ILC2s) that together with other cells in turn 
secrete IL-2, IL-4, IL-5, IL-9 and IL-13 38. Of importance, an increased mucus secretion in 
globet cells will be induced by IL-13. To prevent recognition or limit the effect of recognition 
by the innate immune system the worm release molecules which block toll-like receptor (TLR) 
ligand-induced dendritic cell and macrophage activation 39.  
Adaptive immunity against intestinal nematode infections are characterized by a strong Th2 
type response which in chronic infections is accompanied by a regulatory response. The Th2 
response can be divided in three different phases: First the production of typical Th2 cytokines 
like IL-4, IL-5, IL-9, IL-10 and IL-13 by T cells; then the induction of IgG1, IgG4 and IgE by 
B cells; and last, an expansion of eosinophils and alternatively activated macrophages and 
immunoregulatory monocytes 40. Th2 responses are important to promote worm expulsion. For 
instance, , IL-4 and IL-13, which promote mucus production and smooth muscle contractions 
in the upper intestine are or particular importance 41. IL-4 and IL-13 may have compensatory 
function and recent studies showed that IL-4 null mice can expel the gastrointestinal nematode 
Nippostrongylus brasiliensis 42. However, when IL-13 was investigated, IL-13 null mice 
animals failed to clear N. brasiliensis infections effectively and IL-13 was shown to be an 
important link to the production of intestinal mucus, which therefore facilitates worm expulsion 
43. After expulsion, a resolution stage will take place with a solved inflammation and tissue 
reparation. This step will also be partly orchestrated by type 2 cytokines, but it will also include 
macrophages and eosinophils which will be involved in wound healing and tissue generation 
44. Eosinophils are also responsible for the generation of IgA-secreting plasma cells in the small 
intestine via IL-1β production 45.  
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In addition, there is consistent evidence about the induction of regulatory T cells (Treg) during 
different helminth infections, mostly at chronic stages. In chronic infections, a hypo-responsive 
state will evolve to reduce the damage of the immune response and control the balance. This 
state will be favorable both for the long-term survival of the worms, as for the host protective 
immune responses.  
The expression of Foxp3, the IL-2Rα chain (CD25) and the production of the anti-
inflammatory cytokines IL-10 and TGF-β are characteristic of Tregs. An important expansion 
of CD4+ CD25+ cell numbers and Foxp3, together with high expression of IL-10 and TGF-β 
occurred in draining mesenteric lymph nodes (mLN) during a chronic H. polygyrus infection 
46. An effective suppression of Tregs against Th2 immunity was demonstrated in H. polygyrus-
infected mice, facilitating persistent worm infection 47. But Tregs also play an important 
suppressive role, mostly at later stages of infection. For instance, Grainger et al showed an 
inhibition of TGF-β signaling that reduced the worm burden and resulted in an increase of Th2 
responses 48. Moreover, transfer of Tregs (CD25 surface) from H. polygyrus infected mice gave 
protection from airway allergy to sensitized mice 36. An interesting immunoregulatory cytokine 
for H. polygyrus is TGF-β. In chronic infection of C57BL/6 mice, plasma TGF-β levels rise 
threefold over 30 days, but return to baseline within a week of curative drug treatment 49.  
An important issue to solve regarding Tregs is if the expansion occurs within induced 
(adaptive) or natural (thymic) Treg types. During H. polygyrus infection, pre-existing natural 
Tregs expressing the marker  “Helios” were found to be  the first to expand after infection, 
while “Helios-negative” (i.e. adaptive) populations only appeared late and only remained a 
numerical minority of the total Treg compartment throughout the infection 50.   
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1.3. DIABETES AND TUBERCULOSIS  
1.3.1. Diabetes mellitus 
Diabetes mellitus (DM) is the denomination of a set of metabolic diseases that are generally 
defined by the presence of chronic hyperglycemia. The term “mellitus” actually means “honey 
sweet” and was added in 1675 by Thomas Willis because of the sweetness in urine and blood 
from patients  51.  
Currently there are four types of Diabetes:  
1. Type 1 DM (T1DM) which is caused by an autoimmune destruction of β cells in the 
pancreatic islets, leading to complete insulin deficiency.  
2. Type 2 DM (T2DM) that is characterized by a progressive loss of β-cell insulin 
secretion, commonly following the development of insulin resistance.  
3. Gestational diabetes mellitus (GDM), usually diagnosed in the second or third trimester 
and was not evident prior to gestation.  
4. Specific types of diabetes due to other causes like, monogenic diabetes syndromes 
(neonatal and maturity-onset diabetes of the young), exocrine pancreas diseases such 
as pancreatitis, and drug-induced diabetes 52. 
Type 2 Diabetes mellitus (T2DM) is the most frequent type of Diabetes and it has become an 
important global health problem that could aggravate with time. According to the International 
Diabetes Federation, 382 million of adults aged 20-70 years worldwide had type 2 DM in 2013, 
and 80% of this population were from low and middle-income countries with an expected rise 
to 592 million by 2035. Moreover, in 2017 around 4 millions of people died because of type 2 
DM  53. 
Above all the people with DM, only 10-15% have Type 1 Diabetes mellitus. However, T1DM 
is the most common type in children globally, with an estimated number of 90,000 new 
diagnosed children every year 54.  
Despite that hyperglycemia is a common characteristic in all types of DM, the pathophysiology 
will differ on some aspects. Hyperglycemia is the presence of high glucose levels circulating 
in the blood due to defects in insulin levels or signaling. Insulin is a peptide hormone produced 
by the β-cells of the pancreatic islets of Langerhans. It main function is to maintain normal 
blood glucose levels mainly by facilitating cellular glucose uptake and regulating the 
metabolism of carbohydrates, lipids, and proteins 55.  
In T2DM, the defects of insulin are related with an impaired insulin signaling  and a low 
production of insulin 56. Insulin resistance in muscle and liver cells results in a decreased 
glucose uptake and an increased hepatic glucose production that coexists with a defect of the 
pancreatic β-cells to produce enough insulin 57. Moreover, insulin scarcity will increase 
glucagon production by the α-cells in the pancreas, also contributing to excessive glucose 
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production in the liver 58. A simplified scheme of insulin alteration in diabetes is described in 
Figure 1. 
The effect of insulin resistance in adipocytes will result in accelerated lipolysis and increased 
plasma free fatty acid (FFA) levels that will aggravate more the insulin resistance in muscle 
and liver 59. 
The complications of T2DM are related both with the severity and duration of high glucose 
levels in the blood and will also be evident by damage in the microvasculature 60. Several are 
the pathways that contribute to this damage, of importance are the increased formation of 
advanced glycation end products (AGEs) and increased intracellular reactive oxygen species 
61. Damage in a micro- and macrovascular level will increase the risk of cardiovascular risk 
factors and activation of inflammatory pathways 62. Macrovascular complications include 
stroke and coronary artery disease while nephropathy and retinopathy are microvascular 
complications of diabetes 63. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Defect on insulin signalling in T2DM.  
 
1.3.2. Obesity as a risk factor for diabetes 
Hypertriglyceridemia, hypertension, visceral obesity, low high-density lipoprotein (HDL) 
levels together with high fasting plasma glucose will conform a cluster of conditions  that 
increase the risk of T2DM and are also associated with stroke and heart disease 64. 
Central obesity is sign and cause of the metabolic syndrome.  Increasing adiposity, often 
reflected in high waist circumference, may both result from and contribute to insulin resistance.  
Obesity is an important and very prevalent global health problem. Cases had tripled since 1975, 
and in 2016, around 39% of adults globally (18 years old or more) were overweight, and 13% 
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were obese. The situation in children is not better, an alarming number of 41 million children 
under the age of 5 were overweight or obese in 2016, and 340 million children and adolescents 
(5 to 19 years old) were overweight or obese the same year 65. 
The molecular mechanisms that link obesity with DM are mainly related with insulin resistance 
66. Several mechanisms are being studied to understand the predisposition, but maybe the most 
important ones are: the increased production of adipokines/cytokines like tumour necrosis 
factor-α (TNF), IL-6 and resistin 67; an ectopic fat deposition, mainly in liver and skeletal 
muscle 68; and a mitochondrial dysfunction that will decrease insulin sensitivity, compromising 
β-cell function 69.  
1.3.3. Diabetes and immunity: Increased susceptibility to infections 
Obesity is associated with low-grade inflammation and is probably contributing to the 
activation of immune system in patients suffering from T2DM 70. The  pathogenesis of T2DM 
is linked to both innate and adaptive immune responses that are recognized as important 
etiological components in the development of insulin resistance 71. 
Innate responses in obesity/diabetes 
An important accumulation of macrophages in the adipose tissue of obese mice models and 
humans was reported in previous studies. For instance, more than 50% of the adipose stromal 
cells in leptin receptor deficient obese ob/ob mice were identified as macrophages 72. Moreover, 
in obese people, an approximate of 40% of the adipose connective tissue cells was formed by 
macrophages 73. The infiltration of macrophages has been correlated with adipocyte 
hypertrophy 74, and also with the presence of necrotic adipocytes, suggesting that macrophages 
infiltration was due to the release of free lipid from necrotic cells 75 . 
 It is known that macrophages have an stunning plasticity so they can polarize from M1 
classically activated type that produce high levels of ROS and NO but also TNF and IL-6 to 
combat infections, to M2 alternatively activated macrophages 76, that are involved in collagen 
and polyamine production and healing functions as an answer to different stimuli 77.  Obesity 
adipose tissue is mostly populated by M1 macrophages with pro-inflammatory responses, and 
the numbers of M1 macrophages correlates with the presence of insulin resistance 78. For 
example TNF has repeatedly been shown to inhibit different steps in the intracellular insulin 
signaling 79. Evidence showed that when high fat diet-fed mice were changed to normal diet, 
macrophages polarized to M2 and insulin resistance was reduced 80. Moreover, treatment of 
HFD-fed mice with pioglitazone (an insulin sensitising agent), resulted in reduction of M1 
macrophages in tissue 78. These studies show an important role of innate immune responses in 
insulin resistance, a hallmark in obesity and diabetes.   
Glycation is a non-enzymatic reaction that occurs between a carbohydrate and a molecule with 
a free amino group, such as a protein 81. Glycation is a physiological and pathological process 
that produces the so-called glycated proteins and is entirely separate from glycosylation, which 
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represents an enzyme-controlled physiological process that occurs during synthesis of 
glycoproteins.  
Chronic hyperglycemia in diabetic patients leads to glycation of immune components including 
immunoglobulins, diminishing their efficiency to bind complement 81, NK cells, or suppressing 
inflammasome activation 82 and therefore, increased susceptibility to infections. Particularly 
the accumulation of the reactive dicarbonyl metabolite methylglyoxal (MGO), is key in the 
development and accumulation of damage. In this line, MGO was found to inhibit T cell 
proliferative responses. Interestingly, this effect was reversed by N-acetyl cysteine (MGO 
scavenger) 83. Moreover, MGO inhibited the production if IL-10, IFN-γ  and reduced the 
expression of MHC-I 84.  
Adaptive responses in obesity/diabetes 
Similar to macrophages, T lymphocyte accumulation has been found increased in obese 
adipose tissue 85. Moreover, in vitro studies showed that T cells inhibited the differentiation of 
pre-adipocytes to mature adipocytes, therefore contributing to hypertrophic adipocytes 86. 
An accumulation of Th1 and Th17 cells was also found in obese adipose tissue, these cells 
were preceding macrophage infiltration. These proinflammatory T cells will promote 
macrophage polarisation towards M1 pro-inflammatory phenotype 87.  
Lymphocyte deficient mice (such as rag1-/- or rag2-/-  mice) are a very good model to explore 
the role of T cells. For instance, HFD-fed rag1-/-  mice showed increase fat mass and higher 
insulin resistance compared to HFD-fed lymphocyte-sufficient mice 88. Moreover, rag1-/- mice 
that received different CD4+ T cell sub-populations indicated a reversal of insulin resistance 
only  when they were transferred with Th2 differentiated cells, suggesting a protective role of 
Th2 cells from the development of insulin resistance in diet-induced obesity 88. In addition, 
depletion of Treg cells in leptin receptor deficient (db/db) mice lead to increased insulin 
resistance compared to Treg sufficient mice 89. On the other hand, hyperglycemia has been 
shown to lead to an impaired proliferative function of CD4 T lymphocytes 90.  
Susceptibility to infections in DM 
DM is a complex metabolic disease. The impairment or deregulation of immune responses of 
DM patients leads to their higher susceptibility to infections 91. Epidemiological studies showed 
higher frequencies of infectious diseases in diabetic patients, including skin, genitourinary, 
gastrointestinal and respiratory infections 92.  For example, respiratory infections associated 
with DM are caused by Streptococcus pneumoniae and influenza virus 93. The prevalence of 
Hepatitis C has been reported to be increased in patients with DM 94.  
Urinary tract infections (UTIs) are more prevalent in individuals with DM and may evolve to 
complications and/or serious manifestations 90.  Acute pyelonephritis caused by E. coli or 
Proteus sp. is 4–5 times more common in individuals with DM 93. A study in a murine urinary 
tract infection (UTI) model showed that type 1 fimbriated urophatogenic Escherichia coli 
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(UPEC) had an increased adherence to the bladder in diabetic female mice compared with non-
diabetic mice. Moreover, an increased concentration of two AGE’s was found in superficial 
urothelial cells. Interestingly, this binding was inhibited by pre-treating diabetic mice with 
pyridoxamine (an AGE inhibitor) 95. 
Foot infections are a frequent cause of medical attention in DM 96. An important causative 
agent of this infection is Staphylococcus aureus. A study performed with diabetic and insulin-
responding non-obese diabetic mice (NOD) showed a higher expansion of skin lesions 
compared to non-diabetic controls. Remarkably, treatment with insulin ameliorated the skin 
infection produced by S. aureus. Moreover, in vitro studies showed that in the hyperglycemic 
blood the bacteria significantly multiplied, while the non-diabetic blood  showed 68% death of 
bacteria 97. 
1.3.4. Tuberculosis 
Tuberculosis (TB) is a bacterial infection produced by Mycobacterium tuberculosis (Mtb). It 
is a transmissible from person to person, and it spreads through the air via by bacteria 
containing droplets, mainly when an active infected person with Mtb in the lungs coughs, spits 
or sneezes 5. 
An approximate of 10 million new cases of TB occurred in 2017. The incidence has been 1,5% 
approximately lower per year since 2000 (ref). TB is not only an important cause of morbidity 
and low quality of life, but it also caused the death of 1,57 million individuals in 2017. Of 
importance, the incidence of RR (rifampicin resistance) or MDR (multidrug resistance) was 
around 5,6% of total TB cases 98, complicating TB control. Even though the incidence of TB 
decreased globally 99, in resource-limited middle-income countries is still in the top five causes 
of death 100, mainly because of poverty and poor access to health 101. 
Co-morbidities with TB are increasing every year. Among all HIV infected, around 9% are 
also TB infected 99. The risk of developing TB increases around three-times among DM 
patients 102. An improvement of nutrition and living conditions, helped to decline the 
prevalence of TB in the late 19th century.  
Moreover, the introduction of Bacillus Calmette-Guerin (BCG) in 1920 helped to reduce the 
incidence of TB. BCG is the most widely used vaccine in the world.  However, the efficacy of 
BCG is variable, and it has not solved the TB pandemic situation. BCG showed efficacy against 
childhood TB, but the effect in pulmonary TB in adults is still variable at most 103.  
The physiopathology of TB has been broadly studied, but some areas are still unexplored. Most 
individuals infected with M. tuberculosis remain chronically infected but are otherwise 
asymptomatic. However, 10% of infected individuals will develop active TB during their 
lifetime. Why some individuals are resistant to TB, but others show an array of pathologies is 
still not understood, but immune-bacterial interactions are of primary importance in controlling 
the development of infection.    
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Due to the mentioned mechanism of transmission, the primary target organ is the lung. Upon  
TB activation, the bacteria disseminates and disease can develop in any other organ resulting 
in extrapulmonary tuberculosis (EPT) 104. Symptoms during TB are not very specific. TB 
presents a prolonged productive or dry cough, weight loss, fever, and night sweats 99. The TB 
latency spectrum may be further subdivided into diverse stages associated to the  related pattern 
of immune molecules expressed 105 
1.3.5. Mycobacterium tuberculosis 
The causative agent of TB is an obligate intracellular pathogen whose principal hosts are human 
beings 106. Mtb is an aerobic bacillus (motive for lung preference as habitat), but can also 
survive in hypoxic environments where it can switch its metabolism to a dormant or latent 
phase. Mtb is not-encapsulated, non-motile, acid-fast and it does not form spores 98. The 
interactions between Mtb and the host are complex 98. 
Mycobacterium bovis - Bacillus Calmette Guerin (BCG) 
Genomic differences between Mtb and BCG helped to define a particular region of  difference 
called RD1, a main explanation of the lack of risk or progression to disease of around 4 million 
of children that have been vaccinated 107,108. 
The importance of RD1 is that it encodes a bacterial secretion system, known as ESX-1 109.  
ESX-1 delivers bacterial molecules into the host cell cytoplasm and allows bacterial to survive 
in such environment 110. The use of BCG in in vitro macrophage infections has been shown as 
a proper model to study inflammatory responses as well as host-mycobacterial interactions. 
Low multiplicity of BCG infection of macrophages has been shown efficient to stimulate high 
levels of bactericidal or bacteriostatic proinflammatory responses (i.e. IL-1β and iNOS) and 
has a decreased cytolytic activity compared with Mtb infection 111.  
 
1.3.6. Immune responses to Mycobacterium tuberculosis 
The host-pathogen interaction in TB is a complex with different responses played in response 
to Mycobacterium tuberculosis infection. 
Innate responses to Mtb  
To control the fragile balance between the host and the microbial infections, the host has 
developed a broad arsenal of innate immune mechanisms. These include physical barrier 
functions, soluble effectors such as complement and antimicrobial peptides, and phagocytic 
cells. The critical role of phagocytes in host defense lies in their rapid mobilization and 
recruitment into o the tissue and their ability to recognize and inactivate pathogens following 
the activation of effector microbicidal responses.  Phagocytes such as macrophages or 
neutrophils are recruited to the tissue in response to invading microorganisms. In the inflamed 
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tissue these phagocytes contribute to local inflammation. The inflammation encompasses an 
increased amount of monocyte extravasation and tissue accumulation. 
The role and characteristics of innate immune responses during M. tuberculosis infection has 
been studied in diverse animal models. Murine, but also in rats, guinea pigs and non-human 
primates have been used for this purpose.   
Following inhalation, Mtb move via the respiratory tract and until encountering alveolar 
macrophages, the most important cell target for this intracellular pathogen 112,113. Macrophages 
internalize the bacteria by a receptor-mediated phagocytosis. Bacterial immune innate receptor 
agonists include peptidoglycans, glycolipids such as PIM, LAM and ManLAM and bacterial 
unmethylated CpG containing DNA. These  molecules will activate Toll Like Receptors (TLR) 
and also other types of innate immune receptors such as NOD, C-type lectins (dectin-1 and 2), 
STING  and mannose receptors 114.  These receptors are single membrane-spanning receptors 
that will recognize conserved molecules derived from microorganisms 115. Human studies 
showed variable TB susceptibility in patients with TLRs polymorphisms 116.The interaction 
between Mtb ligands and TLRs is mediated by the Myeloid Differentiation Primary Response 
88 (MyD88),  that will later cluster with the  IL-1R associated kinase (IRAK4). The complex 
will activate TNF receptor associated factor (TRAF6), finally resulting in the translocation of 
the NF-kB transcription factor into the nucleus and the transcription of inflammatory mediators 
117. TLRs also activate mitogen-activated protein kinases (MAPK) that activates other pro-
inflammatory transcription factors (AP-1).  
So far, it is known that TLR2 and TLR9 play a minor role  in TB infection if any 118. In vivo 
studies showed that TLR4-null mice resistance to Mtb infection is slightly decreased, together 
with an increase of bacterial growth and diminished survival. On this line, macrophages from 
TLR4-deficient mice produced less TNF-a upon stimulation with Mtb than controls 119. In vivo, 
TLR2-deficiency also lead to diminished resistance against a higher dose of Mtb 117, but more 
studies are needed to keep exploring the function of TLR2 and TLR4 and maybe other TLRs 
involved in TB infection. 
TLR as well as signaling via other receptors results in release of reactive oxygen and nitrogen 
species and also the secretion of chemokines and cytokines. The later will mediate the and 
recruitment and activation of PMNs, macrophages and dendritic cells 120.  
The bactericidal/bacteriostatic arsenal of  murine macrophages above mentioned has different 
degrees of efficiency against M. tuberculosis  121.  Among mycobactericidal mechanisms of 
macrophages  a relevant one is the de novo expression of the inducible  nitric oxide synthase 
(iNOS), which results in the production of the reactive nitric oxide (NO) by the conversion of 
arginine into citrulline 122. The expression of inos mRNA occurs directly in response to 
mycobacterial innate immune stimulation, and occurs in synergy  by TNF (also secreted by 
macrophages after innate immune activation) and IFN-γ released by CD4+T cells 123. 
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The relevance of iNOS derived NO in the microbicidal activity in human macrophages is not 
completely understood.  1,25-dihydroxy vitamin D3 (1,25-(OH)2D3) in combination with  
IFN-γ  and TNF-α activated macrophages inhibited grow and/or killed Mtb in human 
macrophages 124, 125 . 1,25-(OH)2vitamin D3 induced the expression of NOS2 inhibiting Mtb 
activity in human HL-60 macrophage-like cell line 126. 
Adaptive responses to Mtb 
The role of T cells to protect the host against Mtb infection is crucial. Activation of both CD4+ 
and CD8+ T cells is observed in active TB in humans, as well as in infected mice 127. CD4+ Th1 
cells  are thought to be the most critical for bacterial control 127.  CD4+ T cells recruited to the 
infected lung are thought to control infection by producing IFN-γ in response to mycobacterial 
antigens presented by macrophages 127, 128, 129.  In turn, IFN-γ  will activate macrophages to kill 
the intracellular Mtb through NO and reactive oxygen intermediates 130, and by inducing the 
formation of phagolysosomes131,122.  
Mice lacking CD4 T cells, IFN-γ , IL-12 signaling (a pathway required for Th1 development), 
or T-bet (a transcription factor requisite for Th1s) are very susceptible to infection with M. 
tuberculosis 127. Alike, humans with genetic deficiencies in IFN-γ or IL-12 signaling 132, as 
well as HIV-infected individuals depleted of CD4 T cells 133, are severely restricted in their 
ability to contain mycobacterial infections, including TB. CD8 T cells can also help control 
Mtb by both perforin-mediated cytolysis of infected macrophages and direct killing of M. 
tuberculosis 134. 
However, and, different from other infections, T cells will take longer time to be activated in 
the draining lymph nodes and migrate to the lungs. For instance, it has been shown that in 
infected animals specific lung T cells will recognize bacteria in approximately 3 weeks after 
infection, compared to 5-7 days occurring in other infections 135,127. M. tuberculosis may 
directly infect dendritic cells, an impair their migration to the draining lymph nodes and thus 
the activation of naïve T cells will be delayed 136. At a later stage, when T cell priming is 
initiated in the draining lymph nodes, the inflammatory milieu of Mtb infection promotes 
expansion of a highly suppressive population of Mtb-specific regulatory T cells (Tregs). The 
Tregs will impair the activation of anti-mycobacterial T cells, to prevent autoimmunity 137. 
Regulatory T cells were found increased in TB infected lungs  from mice 138 and humans with 
active TB 139 . Studies in mice lacking Treg subsets were performed. However the findings 
were a bit controversial, as Treg depleted mice indeed presented less bacterial load, but the 
mice developed autoimmune damage 138. The proper activation of T cells will also be disturbed 
by the presence of regulatory cytokines (IL-10 and TGF-b) and other immunosuppressive 
factors (i.e. lipids) and by the high bacterial burden 136. All of these results in the presence of T 
cells required to control the infection but with a limited ability to clear it.  
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Granuloma formation  
A human granuloma can be defined as a compact and organized aggregate of mature 
macrophages that develops as a tissue reaction in response to a persistent stimulus 140,141. 
Usually macrophages take the central part and they can present additional changes, like bigger 
and mature with ruffled cell membranes, known as epithelioid cells. They can also fuse into 
multinucleated giant cells or differentiate into foamy cells with lipid accumulation 142.   
Granulomas may present  central region of necrosis due, a “caseum” and are typical in TB 
pathology 143. Moreover, this formation seems to be helpful to contain the bacteria, but a rupture 
of the structure can lead to disseminate the infection 144. 
The granuloma is populated by other cell types apart from macrophages like neutrophils, 
dendritic cells, NK cells, fibroblasts and B and T cells. Moreover, epithelial cells also 
participate in the formation of granuloma and are the ones surrounding the structure 145 
A co-evolutionary perspective seems to be accurate to explain the function of a granuloma, 
since it is not only a structure that will limit bacillary growth and the niche were infection is 
sequestered, but also will be a successful part of Mtb life cycle, helping in its transmission and 
propagation 140.  
1.3.7. Tuberculosis and diabetes comorbidity (TB-DM) 
The interaction between diabetes and tuberculosis is an imperative and complex global health 
concern 102. Diabetic patients have a three-four fold increase risk to develop TB compared  to 
non-diabetic persons 146. 
DM cases are rising not only in high but also low-income countries, leading to “double-trouble” 
effect 147. DM might increase the severity of TB disease, and the relapse and treatment 
responses 148. 
The occurrence of TB-DM has been noticed several years ago. Already in 1934 studies in 
patients showed that TB in adults and adolescents with DM was more common than expected, 
but no specific clinical issues were found when compared to non-diabetic patients 149. Recently, 
several epidemiological studies supported that both the TB prevalence and the risk of infection 
increased among DM patients. This created an interest in understanding the involved 
mechanisms of comorbidity 146,150. 
Regarding the clinical presentation and severity of infection in TB-DM patients, a lower lung 
involvement in radiographic findings in TB-DM patients was more pronounced compared to 
non-diabetic 151 . Moreover, a multilobar-cavity pattern was more usual in TB-DM patients 152. 
It has been mentioned before that DM alters protective immunity to infections. Some studies 
indicated that mycobacterial burden might be higher in DM than controls, which could also 
show an impaired response to treatment 146. In one study, similar sputum conversion 
proportions were found after two months of TB treatment in both TB-DM and non-diabetic TB 
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patients. In contrast, another study showed a longer conversion time of sputum in DM patients 
153,154. Alterations in the immune responses were evident in one study on TB-DM patients, 
showing that innate and Th1 responses were significantly higher compared to controls 155 . The 
effect was consistently and significantly more marked in DM patients with chronic 
hyperglycemia. 
The possible mechanisms involved on the increased susceptibility to Mtb infection where 
studied in few DM animal models.  DM is modelled in both obese and non-obese animal 
models with varying degrees of insulin resistance and beta cell failure.  
 In chemically, streptozotocin-induced mice models of DM, a high percentage of the 
endogenous β-cells are destroyed, and thus, there is little endogenous insulin production, 
leading to hyperglycaemia and weight loss. A disadvantage with chemically inducing DM is 
that the chemicals can be toxic at other organs of the body.  Mtb-infected streptozotocin-
induced DM mice showed ten times higher phagocytic activity of macrophages and also higher 
mortality than normal mice 156. Moreover, streptozotocin-induced diabetic mice had higher 
bacterial load than normal mice (own data, unpublished).  
Monogenic models of obesity are commonly used in type 2 DM research. The most widely 
used monogenic models of obesity are defective in leptin signalling. Leptin stimulates satiety, 
and thus, lack of leptin in these animals causes hyperphagia and obesity. These models include 
the leptin deficient ob/ob, the leptin receptor deficient db/db mouse and the leptin receptor 
deficient Zucker Diabetic Fatty rat 136, 157. Obese ob/ob mice showed hyperglycemia and lack 
insulin production (ob/ob) displayed higher bacterial loads in the lungs at different time points 
of Mtb infection 158. Mtb-infected db/db mice showed disorganized granulomas, neutrophilia 
and reduced B cell migration to the lungs. Db/db mice also showed increased bacterial load 159. 
Despite that some lights were shown regarding TB-DM synergism, the mechanisms behind 
this interaction remains incompletely understood.  
1.3.8. Hypoxia inducible factor (HIF-1) 
The cells of most living organisms require oxygen to produce energy as ATP and fulfil their 
metabolic activities, development and growth. Hypoxia can result from a failure in the delivery 
of oxygen to cells. Failures might include decreased pressures of oxygen (i.e. at high altitude), 
problems with diffusion of oxygen in the lungs, insufficient accessible hemoglobin, problems 
with blood flow to the tissue, and problems with breathing tempo 160,161. Oxygen deprivation 
in different tissues generate hypoxic environments that may cause cell damage, morphological 
and functional changes. Hypoxia can cause circulatory disorders, and heart, lungs and brain 
necrosis. It might also diminish responses to tumors. To prevent this, mammals have developed 
a sophisticated physiological network to maintain oxygen homeostasis. One of the major 
characteristics of this network is the ability to sense and respond to low-oxygen conditions. 
The initiation of these responses to hypoxia is quite fast and involves both transcriptional and 
post-transcriptional mechanisms 162. 
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Although hypoxia is often thought of as being a pathological phenomenon, the mammalian 
embryo in fact develops in a low-oxygen environment and hypoxia affects ultimately 
morphogenesis of the embryo and placenta 163,164.   
HIF-1 was described due to its role in inducing erythropoietin (a hematopoietic growth 
hormone) in renal interstitial fibroblasts under hypoxia.  as this will increase blood oxygen 
transport 165. HIF-1 is a key regulator of a broad range of cellular responses to hypoxia in 
mammalian cells. There are over 200 genes that increase their gene expression either directly 
or indirectly by HIF-1  166 of which 70 have been reported to be directly induced by HIF-1 167.  
Some target genes promote anaerobic metabolism to reduce oxygen use, while others 
“alleviate” hypoxia by acting non-cell-autonomously to extend and modify the surrounding 
vasculature 163. HIF pathways are involved in erythropoiesis, angiogenesis, cell growth and 
differentiation, survival and apoptosis; all are critical factors in development, physiology and 
disease 168. 
HIF-1 is a heterodimeric helix-loop-helix transcription factor formed by two subunit proteins.  
The expression and stability of the α subunit (HIF-1α) is regulated by a family of oxygen- and 
iron-dependent prolyl hydroxylases. The subunit (HIF-1α) is constitutively expressed and is 
also called ARNT (aryl hydrocarbon receptor nuclear translocator). In normoxic conditions 
HIF-1α is hydroxylated on proline residues. The hydroxylation targets HIF-1α for degradation 
in a process dependent upon the recognition by the von Hippel–Lindau tumour-suppressor 
protein (vHL) 169. VHL is the recognition component of an E3 ubiquitin-protein ligase that 
targets HIF-1α for ubiquitylation and proteasomal degradation 170. 
 
Figure 2. HIF-1α stabilization pathways in an Oxygen-dependent and Oxygen-independent manner. HIF-1α 
degradation: 1. Hydroxylation; 2. Recognition; 3. Ubiquitination 4. Proteasomal degradation. 
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If the prolyl hydroxylases are inhibited, HIF-1α will not be degraded, but accumulated.  HIF-
1α will then translocate to the nucleus and dimerize with HIF-1a. The heterodimeric complex 
HIF1 will then bind to the HRE (Hypoxic reactive elements) in promoter or enhancer sequences 
of target genes. A nuclear activator and a corepressor regulate HIF-1 transcriptional activity. 
The coactivators are p300 and CBP, and they will catalyse acetylation of histone proteins and 
initiation of gene transcription. The corepressor has multiple isoforms and that are regulated 
by histone deacetylases (HDACs) 168, 169, 171. A simplified scheme of HIF-1α stabilization in 
hypoxic or normoxic conditions is depicted in Figure 2. 
1.3.9. HIF-1α and immunity/infections 
Innate immunity and HIF-1α 
During infection, the intense metabolic activity of activated phagocytes will, together with the 
oedema, vascular damage and tissue destruction, reduce the amount of oxygen in the tissue. 
The inflamed tissue is characterized by low levels of oxygen and glucose coexisting with high 
concentrations of free oxygen radicals and lactate 172. Phagocyte activation in these conditions 
generates ATP via glycolysis.  
HIF-1α is expressed in most if not all innate and adaptive immune populations including 
macrophages 173, neutrophils 174, dendritic cells 175, and lymphocytes 176.  
The control of cellular metabolism by HIF-1α has been shown to play an important role in cells 
that are protagonists of the first line of defence against infections. While the  development/ 
differentiation of innate cells like monocytes, macrophages and neutrophils doesn’t seem to be 
affected by HIF-1α deletion173, the activation of  cells  of the innate immune system by 
microbial products or infection  switch their metabolism  from mitochondrial oxidative 
phosphorylation to HIF-1α-mediated aerobic glycolysis (also known as the Warburg effect in 
cancer cells),  as well as by an upregulation of pathways involving oxidative defense responses, 
arginine metabolism, and synthesis of bioactive lipids 63.  This will provide an adaptation to 
demanding conditions such as lower levels of oxygen in injured tissues in order to maintain 
viability and activity. Because the upregulation of most glycolytic pathway enzymes is 
mediated by HIF-1α177 169, a role for this transcription factor in supporting phagocyte function 
during inflammation could be predicted.  
Macrophages with impaired HIF-1α levels were less capable to aggregation, invasion and 
motility178. HIF-1 will boost microbicidal activation of phagocytes. HIF-1 will promote the 
activation of the innate immune cells, promoting phagocytosis, increasing phagocyte lifespan 
by inhibiting apoptosis, releasing pro-inflammatory cytokines and antimicrobial peptides, and 
importantly, activating production of NO169 as well as of reactive oxygen species. Of 
importance phagocyte activation, was shown to be dependent on HIF-1α even when it occurred 
in normoxic conditions 179. 
It is important to mention that every inflamed tissue will activate the transcription factor NF-
kB. Moreover, the hypoxic environment created by inflamed / infected tissues has been shown 
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to activate both NF-kB and HIF1 (references). Therefore, an important crosstalk between NF-
kB and HIF-1α was investigated. In fact, there are evidences that NF-kB will modulate and 
stabilize HIF-1 after microbial stimulation (references). However, the situation of NF-kB when 
HIF-1 is first stabilized is still not completely unravelled. For instance, HIF-1α has been shown 
to restrict NF-κβ transcriptional activity in vivo and in vitro under inflammatory conditions 180, 
but this mechanism needs to be studied further. 
Cytokines and HIF-1 
IL-1β is a major macrophage-derived pro-inflammatory cytokine that is upregulated in both 
inflammation and infection. The maturation of IL-1β is mainly due to activation of the 
inflammasome, a complex of NLRP-3, an adaptor protein and caspase-1 that will be activated 
in response of microbial products among others 181.  A study about HIF-1 and IL-1β in an 
ovarian carcinoma cell line, showed that IL-1β induced the expression of adrenomedullin 
mRNA (a peptide related with vascular homeostasis in hypoxic environments) by activating 
HIF-1 under normoxic conditions, and presented increased accumulation and nuclear 
translocation of HIF-1α 182. Recently, an interesting link between succinate accumulation in 
LPS stimulated macrophages and IL-1β has been described. Succinate is transported from the 
mitochondria via the dicarboxylic acid transporter to the cytosol, impairing PHD activity and 
therefore promoting HIF-1α stabilization (pseudohypoxia), this effect produced an important 
augmentation of il1b mRNA of BMM treated with diethyl succinate and stimulated with LPS. 
In contrast, BMMs from HIF-1α deficient mice had less IL-1β protein and mRNA levels after 
stimulation, and treatment with diethylsuccinate had no effect on IL-1β secretion.  
In line with this, PKM2 (pyruvate kinase M2), an inactive dimer of piruvate kinase enzyme, 
has been shown to be a critical modulator of IL-1β production through HIF-1 stabilization, as 
well as of glycolitic reprograming in LPS-activated macrophages. There is a clear inhibition of  
LPS-induced HIF-1α and IL-1β as well as the expression of important HIF-1α dependent genes 
when PKM2 is activated as a tetramer, therefore this can be an important target for improving 
immune responses 183.  
Several studies have correlated and increased production of NO with HIF-1α stabilization in 
infections. For instance, it has been shown that HIF-1 is stabilized with deferoxamine (DFO).  
DFO induced inos mRNA expression and iNOS transcription in IFNγ-treated murine 
macrophages (reference). DFO induced the binding of HIF-1 to a  hypoxia-responsive enhancer 
in the inos- gene promoter 184. Moreover, a direct transcriptional activation of inos gene 
expression in myocardial cells exposed to hypoxic conditions has been shown185. In addition, 
the accumulation of HIF-1α was prevented by inhibition of NOS activity, indicating that NO 
might also be responsible for the accumulation of HIF-1α 186. HIF-1α function requires NO 
production, and that HIF-1α and iNOS are linked by a positive feedback loop that amplifies 
macrophage activation 187. 
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Adaptive immunity and HIF-1α 
The consequences of HIF-1α functions are not only limited to the myeloid lineage. There is 
considerable evidence that HIF-1α has an important role in the modulation of T cell functions. 
As with innate immune cells HIF-1 functions in T cells can be increased in an oxygen-
independent manner, via T cell receptor activation or by defined cytokines.  
Studies on HIF-1α function in CD8+ T cells infiltrating T cells in tumours showed that T cells 
utilized HIF-1 to adapt to the hypoxic tumour microenvironment (ref). HIF-1α, but not HIF-2α 
was essential for establishing effector functions of  CD8+ T cells and loss of HIF-1α in CD8+ 
T cells reduced tumor infiltration and tumor cell killing 188. 
Another study used mice with VHL deletion in CD8+ T cells, leading to HIF-1α stabilization. 
This deletion promoted the glycolytic metabolism after the T cell receptor activation. Such 
HIF-1α activation of glycolysis accelerated the differentiation of CD8+ memory T cells during 
viral infection. Increased glycolysis was required for the posterior formation of long-lived 
effector-memory CD8+ T cells, which showed a mitochondrial oxidative phosphorylation 
metabolism. These results indicated an important link between cellular metabolism and 
memory CD8+ T cell differentiation189. Yet, the role of HIF-1 in the regulation of adaptive 
immunity is still controversial and needs further investigation. 
Some studies have shown that HIF-1α instead might suppress some effector functions of CD4+ 
T cells. In fact, the release of TNF and IFN-γ was increased in T cells lacking HIF-1α gene 
compared to wild type T cells 190 191. Thus, while metabolic reprogramming occurs during the 
activation of all T cells their effects can be different with respect to the usage of HIF-1 pathway.  
1.3.10. HIF-1 role in obesity/diabetes 
Obesity, as discussed above, is a health problem that  frequently co-exists with type 2 DM, 
leading to the so called "diabesity epidemic" 192. The rising incidence of type 2 DM among 
children and adults is related to the epidemic of obesity. The adipose tissue has been shown to 
create an hypoxic environment caused by the presence of a moderate chronic inflammation 193. 
The obesity-associated factors hypoxia, adipogenesis and insulin, all elevated HIF-1α protein, 
but only adipogenesis and insulin enhanced HIF-1α mRNA activity. Moreover, VEGF (a major 
target gene of HIF-1) was also upregulated due to the need of for angiogenesis for further 
growth of the adipose tissue 194. 
HIF-1 and Hyperglycemia 
The regulation of hyperglycemia on HIF-1α activity is still not completely understood. On one 
side hypoxic lesions from different organs like heart and retinas in diabetic rats showed HIF-1 
upregulation 195. On the other hand, there are few hypotheses explaining the HIF-1α 
deregulation by hyperglycemia. For instance, a negative effect of reactive oxygen species 
(ROS) trough methylglyoxal (MGO)has been postulated. MGO is a dicarbonyl compound that 
can be found in all cells since it is a by-product of cellular metabolism, more specifically of 
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glycolysis 196. This means that if the concentrations of their precursors are elevated, as for 
example during hyperglycemia   MGO levels will increase. MGO are highly reactive glucose 
metabolites that form stable adducts (glycation) primarily with arginine residues of intracellular 
proteins 197. Among these proteins, MGO can cause a covalent modification of HIF-1α and a 
decreased dimerization of HIF-1α and HIF-1β, reducing the binding of HIF-1 to the HRE 
(hypoxia responsive elements). The covalent modification of p300 will lead to inhibition of the 
interaction of CTAD (carboxy-terminal transactivation domain) and p300, which will decrease 
the transactivation ability of HIF-1α 198. Moreover, the covalent modification leads to HIF-1α 
proteasomal degradation 199. Figure 3 describes the possible pathways of HIF-1α 
destabilization through methylglyoxal (MGO). 
MGO is a potent inducer of oxidative stress and AGEs (advanced glycation end products). In 
diabetic patients both MGO and oxidative stress levels are increased, and accompanied by a 
reduction of   antioxidant defences and a constant ROS/AGE formation 200.  
A direct regulatory role of ROS on HIF-1α has received attention. However, the existing body 
of literature shows contradictory findings 201. A reaction between O2 and NO results in a 
decreased NO concentration, reducing  NO-induced HIF-1α accumulation and activation 202. 
On the other hand, HIF-1α accumulation in hypoxic tissues is blocked by antioxidants 203.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Possible mechanisms of Hyperglycemia and HIF-1α destabilization trough Methylglyoxal (MGO).  
A. MGO causes a covalent modification of HIF-1α and decreases its dimerization with HIF-1β and binding to 
HRE; B. A covalent modification of p300 inhibits its interaction with CTAD, therefore decreasing the 
transactivation ability of HIF-1α and C. A covalent modification of HIF-1α increases its association with 
HSP40/70, which recruits CHIP and produces HIf-1α proteosomal degradation. Modified from Xiao et al 
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Finally, it is important to keep in mind that in DM both hypoxia and hyperglycemia are present.  
Thus, cells might not be capable to respond well to hypoxia, increasing the risk of 
complications. During DM the expression of HIF-1α has been shown to be reduced in a 
relatively major area of hypoxic lesions 195. While hyperglycemia has been suggested to 
modulate HIF-1α functions, whether this malfunctioning of the HIF-1α pathway can underline 
the failure to control infections in hyperglycemic conditions has so far not been studied.   
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1.3.11. HIF-1 role in Tuberculosis 
Among other pathological features in TB, the existence of hypoxic lesions has been 
demonstrated. Direct determination oxygen tension in rabbits 204, and indirect measurements 
in macaques and humans using hypoxia-sensitive probes demonstrate that several TB lesions 
in vivo are hypoxic 205 206. In man, TB granulomas can consist of a caseous necrotic centre 
surrounded by a cuff of T cells. Mycobacteria often reside within necrotic tissue that has no 
obvious supply of oxygen 204 were it differentiates into a dormant/ latent stage. It is likely thus 
that HIF-1α plays thus a role in the immune control of bacteria in the lesions.  
In vitro and murine studies have shown an upregulation of HIF-1α during Mtb infection, 
opening doors to study a possible role of HIF-1α in regulating immune protection 187, 207.  The 
expression of HIF-1α showed a progressive increase during Mtb infection.  HIF-1α expressing 
macrophages were already detected in the first month of infection in mice. The HIF-1α 
expression was higher during the late phase (day 60) 208. A strong expression of HIF-1α was 
observed in TB granulomas  209,208.  
Mice lacking HIF-1α in the myeloid lineage were highly susceptible to Mtb infection and 
exhibited defective production of inflammatory cytokines and microbicidal effectors. In one of 
these studies HIF-1α was shown to regulate the responses to IFN-γ . On the other hand, HIF-
1a levels were higher in IFN-γ activated, Mtb- infected macrophages. Although IFN-γ is a 
critical host-protective cytokine against intracellular pathogens, HIF-1-deficient macrophages 
permitted M. tuberculosis growth even after activation with IFN-γ 209. RNA-sequencing 
demonstrated that HIF-1α regulated half of the IFN-γ  inducible genes in Mtb infected 
macrophages 210. HIF-1α was found to be linked to iNOS and NO by a positive feedback loop 
that amplifies macrophage activation during Mtb infection. Moreover, NO at the same time as 
shown to inhibit NF-kB activity to prevent hyperinflammatory responses, regulating thus on 
one side the HIF-1α-mediated microbicidal response and on the other limiting the NF-kB 
inflammatory damage 187.  
Lipid droplets are formed in M. tuberculosis infected macrophages. It has been shown that IFN-
γ driven, HIF-1α dependent signaling pathway, redistributes macrophage lipids into lipid 
droplets. M. tuberculosis were able to acquire host lipids in the absence, but not in the presence 
of LDs. HIF-1α and IFN-γ  were also required for the formation of lipid droplets in the lungs 
of M. tuberculosis infected mice 211.  
Studies performed in zebrafish also showed an important participation of HIF-1α in a 
Mycobacterium marinum infection (Mm) 212, 213. Mm-infected zebrafish mimics some key 
features of human TB, including formation of granulomas. When HIF-1α was stabilized in 
zebrafishes the bacterial burden was decreased. This effect was mediated by a NO-dependent 
mechanism 212. An upregulation of IL-1β transcription was detected in the forming stage of the 
granuloma of zebrafishes, at 6 to 8 h post-infection. This correlated with an early upregulation 
of HIF-1α signalling showing an immediate proinflammatory response. Of note, HIF-1α 
activation was transient and not sufficient to control the infection, but when HIF-1α was primed 
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with high IL-1β and NO a lower infection levels were achieved 213. In a model of mouse 
infection with Mycobacterium avium that generates encapsulated necrotic granulomas, the 
presence of necrosis was accelerated in the absence of HIF-1α  214.  
Studies about the role of HIF-1α in human TB are still scarce. Granulomas with a necrotic core 
in the lungs of TB infected patients showed hypoxic areas. In this line, high HIF-1α expression 
was detected by immunohistochemistry in post-mortem lung samples from TB patients 
compared to controls 205. Moreover, a positive correlation between HIF-1α  nuclear expression 
and the presence of Mtb antigens was found, as well as a higher expression of both compared 
to lung tissue from the control group 205.  
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 AIMS 
The general aim of my thesis was to study the interactions between nutrition, immune responses 
and infections. This aim includes three important areas that are continuously interacting in 
health and disease and are quite broad. Very different and specific set ups were used to address 
these interactions in the studies herein presented.  
 
• The first aim (related to paper I) was to study and compare the nutritional status in 
children from different socio-demographic areas, opting for communities situated in 
the highlands (3600-4000 masl) and lowlands (600 to 800 masl) from Bolivia. In line 
with this, another purpose was to study the prevalence of intestinal parasitic infections 
(IPIs) in these children and to find a possible correlation between nutritional parameters 
and IPIs prevalence. This study permitted to explore and understand the interaction 
between nutritional and environmental conditions in children. 
 
 
• The second aim (related to paper II) was to investigate mechanisms that can explain 
how intestinal nematode infections modulated immune responses to secondary 
infection or vaccination at distal sites. This study permitted to investigate the outcome 
of chronic worm infections and the modulation of immune responses. 
 
 
• The third aim (related to paper III) was to investigate the effect of obesity/diabetes in 
the outcome of tuberculosis infection and the role of HIF-1α in this co-morbidity. In 
this study, the molecular mechanism behind the detrimental interaction between DM, a 
metabolic disorder associated to obesity, and tuberculosis was studied.  A possible 
impairment of the function of HIF-1a, a transcription factor involved in the modulation 
of metabolic and immune protective responses against infections, in the TB-DM 
comorbidity, was investigated. 
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 METHODS 
The procedures and techniques used to perform all the studies that comprise this thesis are 
described in every paper/manuscript. In this section, the intention is to expand the information 
about the experimental mice models and in vitro methods used to investigate and reach the 
aims. 
3.1 EXPERIMENTAL TUBERCULOSIS: MICE MODELS OF TB 
In paper III a model of tuberculosis that offers efficient tools to analyse the host response in 
Mtb infection was used. Most of the studies to understand host-pathogen interaction were 
performed in mice. Here we describe the benefits and weaknesses of this model 215, 216 . 
Advantages and Disadvantages of a TB mice model 
ADVANTAGES DISADVANTAGES 
 
• Study the molecular basis of Mtb 
virulence  
• Availability (resistant/susceptible 
strains) 
• Targeted mutant strains (could 
develop similar human pathology) 
• More analytical reagents available 
• Less expensive than host species 
• Similar immune responses 
 
 
• Disease pathology differs from 
human TB 
• It lacks a latency stage 
• Still controversial if it is an 
appropriate model to answer some 
of the problems in TB human 
disease: susceptibility, major lung 
involvement, vaccination 
difficulties 
 
 
We used a resistant strain (C57BL/6) with a median survival time of 250 days when infected 
via aerosol with a low dose Mtb Harlingen strain. Susceptible strains, like DBA/2, C3H, CBA 
and others have a median survival time of 100 days 217.  Db/db mice were also infected. 
In paper III, 100% of mice used in all the experiments were infected via aerosol. The dose used 
was ca 200 CFU (colony forming units) when measured in the lungs one day after infection.  
Previous set up in our lab showed that mice infected via aerosol with the same technique 
presented consistent numbers of mycobacteria implanted in the lungs 218.   
A nose-only aerosol exposure unit (In-tox Products, New Mexico, USA) was used for infection. 
A 15-ml suspension of 1×106 Mtb per ml was loaded into a nebulizer, and placed animals 
inhaled the bacteria aerosol within 20 min. The advantages of an aerosol infection compared 
to an intravenous route are several. For instance, mice inoculated intravenously develop a 
systemic infection that is distributed to several organs differing on the priority of infection; 
generally, around 90% of the bacilli localizes in the liver, 10% in the spleen and around 1% in 
the lungs. Therefore, lung infection iv route is possible, but the CFU load will be lower, around 
5 x 105 CFU in the lungs 129.  
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The aerosol infection simulates the route used in the human natural infection with Mtb which 
targets the lung as a primary organ. Mtb has a very slow replication. Importantly, about 20 days 
after infection, an initial period of logarithmic bacterial growth takes place in the lungs, 
followed by a stationary phase of infection that is dependent on the onset and maintenance of 
adaptive immunity. This period will persist for 250-300 days 219. We observed the presence of 
granulomas in all infected mice. Lungs showed several scattered macroscopic granulomas 
combined with disseminated inflammatory lesions. The severity of these lesions apparently 
increased somewhat from one to three months of infection.  
The infection will not be confined only to the lungs, but, as in the human infection, 
dissemination via lymph and blood will take place, infecting other organs. The bacterial level 
in these organs will be lower than in the lungs 220.  
In our experiments, mice were sacrificed either after one or three months of infection. Bacteria 
from lung and spleen lysates were plated and quantified on Middlebrook 7H11 agar containing 
10% enrichment of oleic acid, albumin, dextrose, catalase, 5µg amphotericin B per ml and 8 
µg/ ml polymyxin B grown for 3 weeks at 37°C. 
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3.2. THE DB/DB MODEL  
A very well defined obese/diabetic model was used to study the outcome of Tuberculosis 
infection in paper III. This is a mutant congenic strain known as the BKS-Leprdb/db/JOrlRj and 
lacks the functional leptin receptor 221. Some important characteristics of the model will be 
explained in this section.  
 General description of the db/db model 221,222  
MICE STRAIN MODIFICATION EFFECT 
 
BKS-Leprdb/db/JOrlRj 
Background 
(C57/BL/6J) 
 
Mutation of the Leprdb gene 
located in chromosome 4 
 
Compensatory hyperplasia 
of the β cells in the islets of 
Langerhans 
 
MODEL PHENOTYPE SYMPTOMS 
 
Type II Diabetes 
(obesity-related) 
 
• Hyperglycemic 
• Hyperinsulinemic 
• Insulin resistant 
• Peripheral 
neuropathy, 
Cardiomyopathy 
• Lipocyte-defects 
• Hypothalamus, 
pituitary gland and 
pancreas alterations 
 
 
Black, obese at 3 to 4 weeks of 
age 
 
• Insulin increase in plasma at 
days 10 to 14 
• Hyperglycemic at 4 to 8 
weeks 
• Increased circulating total 
cholesterol (including HDL, 
LDL and VLDL) 
 
Affected mice present: 
 
 
• Excessive hunger, 
increased appetite 
(Polyphagia)  
• Excessive thirst 
(Polydipsia) 
• Frequent urination 
(Polyuria) 
• Delayed wound healing 
 
 
Six-week old BKS(D)-Leprdb/JOrlRj (db/db) leptin receptor deficient mice and C57BL/6 mice 
were used. The mice are already obese at this age. Weight was measured before and throughout 
the infection and compared to that of WT C57Bl/6 animals.  Blood measurements like glucose, 
HbA1c (glycated haemoglobin), cholesterol and triglycerides were determined periodically. 
Weekly measurements of weight and blood glucose were performed after infection. Cholesterol 
and triglycerides were determined every two weeks and HbAc1 was measured before the 
challenge and after three months of infection.  
Most of the mice presented polyuria, polyphagia and polydipsia; therefore, constant access to 
food and water and cage changes were performed. No deaths were recorded during the infection 
but db/db mice lost weight at starting before 3 months of infection. 
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3.3. HIGH GLUCOSE EXPOSURE OF MURINE BONE MARROW DERIVED 
MACROPHAGES (BMM) 
In paper III, all in vitro experiments were performed on murine BMM.  Tibias and femurs from 
mice of the strain of interest were harvested and the bone marrow was flushed with a PBS-
filled syringe. Bone marrow cells differentiate into BMM 6 days after culturing with M-CSF 
containing medium in macrophages as described 223. In all the experiments, BM cells were 
exposed to normal “euglycemic” 5mM glucose conditions using DMEM media throughout. 
Alternatively, DMEM-25 mM glucose media was replaced 72 h after BM culture. Next, BMM 
were infected and further cultivated in high or normal glucose containing media.  
 
 
  33 
 RESULTS AND DISCUSSION 
 
 4.1  PAPER I:  DIFFERENCES IN NUTRITIONAL AND HEALTH STATUS 
IN SCHOOL CHILDREN FROM THE HIGHLANDS AND LOWLANDS OF 
BOLIVIA 
 
Malnutrition is a global health concern that affects the development of every individual and the 
collective population. Bolivia is a country that has one of the highest prevalence of 
undernutrition among the Andean countries and is still one of the poorest in Latin América. 
However, a map showing the nutritional prevalence in different regions of Bolivia is still 
missing. Data regarding the nutritional situation in remote communities of Bolivia is scarce 
and unactualized. Therefore, their population becomes neglected in both, the Bolivian 
Lowlands and Highlands. Nutritional parameters in children, a vulnerable population, were 
determined. Clinical information, anthropometrical parameters like weight and height; 
haematological and biochemical indicators and examination of parasites in stool were collected 
from 120 children from rural Taraco (Highlands) and 96 from semi-urban Caranavi 
(Lowlands), both predominantly of Aymara indigenous ethnicity. 
 
Questions 
 
¨ What is the nutritional situation in children from the Bolivian Lowlands and Highlands? 
 
¨ Do the environmental and socio-demographic conditions affect the nutritional status in 
children from the Bolivian Lowlands and Highlands? 
 
Main findings 
 
Overweight and obesity were notably prevalent in scholar children from the Bolivian 
Lowlands.  
A surprising prevalence of 41% over-weighted and obese children aged 6 to 12 years, was 
found in the community of Caranavi, in the Lowlands. In contrast, only 3% of children included 
in the study were undernourished.  
 
Severe nutritional concerns, including undernourishment, hypovitaminosis D and anaemia 
were found in scholar children from the Bolivian Highlands.  
Around 11% of scholar children aged 6 to 12 of Taraco community in the Highlands, were 
undernourished, and 6,7% were stunted. In contrast to Caranavi, only 8% were obese or over-
weighted children. Around 60% of all children showed insufficient vitamin D levels, but 
similar prevalence was also found in the Lowlands. As for anaemia, a very high prevalence of 
74% was found. Socio-demographical and environmental conditions played an essential role 
in children’s nutritional situation  
In Taraco, a community with dry soil, low vegetation and a cold climate (typical from a 4000 
masl area in the Highlands); undernourishment, anaemia and hypovitaminosis D were found. 
Moreover, two species of intestinal parasites that usually indicate poor hygienic conditions 
were identified, Hymenolepis nana (H. nana) in 78% and Entamoeba coli (E. coli) in 21% of 
all stool samples, confirming the precarious sanitary circumstances. 
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Caranavi, a better developed semi-urban community in the lowlands, showed improved 
hygienic conditions in school-children, and the same parasites were less prevalent, 29% of H. 
nana and 8% of E. coli. 
 
Discussion 
 
The study of two different socio-demographical and environmental communities, allowed to 
identify some possible health consequences of the nutritional/ hygienic situation in 
schoolchildren. 
On one side, a community in the Highlands, a dry environment, with very low availability of 
nutrients during the whole year 224, contributes to all the severe nutritional conditions found in 
children. Stunting is perhaps the best example to show that a situation of poor nutrition and 
repeated infections are key for a growth impairment, this parameter is measured as height-for-
age following the WHO Child Growth Standards median  225. However, the growth curves used 
as standards are still not adapted to specific conditions (like high altitude), therefore, a “normal” 
growing curve remains unknown as a reference for high latitudes with low oxygen pressure.  
 
While the current information and statistics about nutrition in Bolivia are scarce, most studies 
are focused in undernourishment, mostly in children. In contrast, little data exists regarding the 
other face of malnutrition: overweight and obesity that are highly increasing worldwide 5. The 
rural to urban development usually is followed by improvements of living conditions. Better 
sanitary systems, school infrastructure and housing condition help to prevent exposure to some 
diseases. Yet, this new improved condition is not always well controlled. This was clearly 
noticed in Caranavi, a semi-urban population that is starting to grow, and were all kinds of food 
with high calories, fat and sugar were introduced in the market at very low prices, accessible 
to low- income individuals that are still an important fraction of this community. We 
hypothesize this was a possible reason for the high increase of overweight and obesity found 
in Caranavi. 
 
In this study, one more rural-lowland, subtropical community called “Aguas Turbias - La 
Reserva” was included, and same nutritional parameters were studied in children (unpublished 
data). However, expanding the study to one more location, permitted to identify an interesting 
correlation between urban development and increase of obesity, and, in contrast a lower urban 
development that goes in line with an increased undernourishment prevalence in children. The 
rural community of Taraco in the Highlands (RU-HL) showed a clear example of what 
epidemiologists call “the double-burden effect”, meaning that the presence of both 
undernourishment and overweight/obesity were prevalent, therefore, showing a coexistence of 
both types of malnutrition in the same place (refer to Figure 4). The “double-burden” is a 
phenomenon that is starting to be of concern in many other countries 3.  
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Figure 4. Prevalence of children that are unnourished (UN); overweighed (OW) or obese (OB) in three different 
spots: Rural Highlands -Taraco (RU-HL); Rural Lowlands – Aguas Turbias/La Reserva (RU-LL) and Urban 
Lowlands-Caranavi (UR-LL). (Unpublished data). 
 
Stool samples of children from the three previously mentioned communities were analysed by 
microscopy to determine the presence of intestinal parasites (unpublished data). The prevalence 
of intestinal parasites found in every community is depicted in Figure 5. 
 
Figure 5. Prevalence of intestinal parasites in scholar children from: Taraco (RU-HL); Aguas Turbias/La Reserva 
(RU-LL) and Caranavi (UR-LL). Purple belongs to all children that only presented intestinal helminths; Orange is 
for children that only presented intestinal protozoa; Green belongs to children that presented both helminths and 
protozoa and Grey is the prevalence for uninfected children. 
 
An important finding of the data above described is that the frequency of children with 
helminths (helminths alone + helminths and protozoa) is higher in Taraco (RU-HL) than in 
Caranavi (UR-LL) with 34% and 13,5% respectively, showing that high altitude settings, the 
poor hygiene and low sanitary conditions had a greater influence than a hostile and a high 
altitude geography that is usually not appealing for most of helminth species that prefer sub-
tropical warm environments to fulfil their life cycle 226. Taken together, it can be hypothesized 
that helminths are capable to adapt to different environments and that an improvement of 
sanitary conditions and urbanization can decrease helminths prevalence and the constant risk 
of re-infections. An unexpected fact that is important to mention is the possible administration 
of anti-parasitic prophylactic treatment to children from Taraco and Caranavi few months 
before the study was performed, incident that might had an influence in the parasite prevalence 
obtained. However, it is relevant that even after chemoprophylaxis, the prevalence was still 
high, suggesting that re-infections are constant in these settings.  
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It is important to point out that one of the aims of this study was to evaluate a possible effect 
of intestinal parasitic infections on children’s nutritional status. No correlation was found 
between intestinal parasites and nutritional parameters like anthropometry, Hb, total proteins, 
vitamin D, or zinc. Moreover, the deficient nutritional parameters showed in this study like 
undernourishment, hypovitaminosis D, anaemia, or lower albumin did not correlate with the 
presence of parasites. Constant re-infections in these children leading to asymptomatic 
chronicity, moderate parasitic load, and a combination of pathogenic and non-pathogenic 
species could account for this observation.  
Intestinal parasites might not produce mortality and only severe cases or specific species will 
conduce to clinical symptoms 227 . However,  worm infections are still an important health 
problem that needs to be taken care of, not only due to  their array of acute symptoms but also 
for their long term effects in infected children 228, or the possibility of previously described 
impairment on the efficiency of vaccination. Preventive chemotherapy is still the main 
prophylactic measurement in affected populations229. Moreover, health education, water 
treatment, improved hygienic and sanitary systems, and the reduction of consumption of 
contaminated water or soils are of vital importance, as suggested by our study.  
 
Taken together, this study showed different nutritional deficiencies in the Highlands and 
Lowlands of Bolivia, and the influence of urban, sanitary and socio-economic conditions. 
(Explained in Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Scheme showing the main findings of the study in both Rural and Urban settings, where Malnutrition is 
a shared concern. 
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4.2. PAPER II: ATROPHY OF SKIN DRAINING LYMPH NODES 
PREDISPOSES FOR IMPAIRED IMMUNE RESPONSES TO 
SECONDARY INFECTION IN MICE WITH CHRONIC INTESTINAL 
NEMATODE INFECTION 
 
Intestinal nematode infections are still a major global health concern, especially in rural 
communities of low-income countries 228. Apart from the important morbidity due to chronic 
infections produced by intestinal nematodes, it has been hypothesised that these infections may 
affect immunity to secondary infection and vaccination 230. However, results from studies on 
this subject are divergent.  
This study investigated the effects of intestinal nematode infection on immune responses to 
secondary mycobacterial infection and the underlying mechanisms by which intestinal worms 
modulate immune responses to an infection distal to the site of worm infection.  
 
Question 
 
¨ How can chronic intestinal worm infections modulate immune responses to a secondary 
infection or vaccination in organs and tissues distal to the worm? 
 
Main findings 
 
Chronic Heligomosomoides polygyrus infection leaded to a paucity of lymphocytes in lymph 
nodes distal to the worm infection resulting in a reduced number of lymphocytes available to 
respond upon challenge with a secondary pathogen or vaccination. This finding relates to the 
so called “sink hypothesis” in which the mesenteric lymph nodes drains lymphocytes away 
from superficial skin-draining lymph nodes, which with time shrink. 
Of importance, anti-helminthic treatment recovered LN cellularity, but time was required for 
the lymph node to regain cellularity and responsiveness to secondary antigen/infection. 
 
Discussion 
 
It has been shown that intestinal worm infection suppresses immune responses in conditions of 
allergy, gut inflammation and secondary infection and vaccination 231. Alterations in Th2 cell 
differentiation and increased Treg cell suppressive functions have been some of several 
mechanisms that could be involved in this suppression 30. 
 
In this study, our results support the idea of lymphocyte paucity in the peripheral (not intestinal) 
secondary lymphoid organs in worm-infected mice. To start with, a reduced expansion of 
lymph nodes (LN) draining BCG injected footpad was found. We found no evidences for an 
increased frequency of regulatory T cells or higher levels of anti-inflammatory cytokines. The 
size of skin-draining LNs were smaller in worm-infected mice. However, an effective 
restoration of cellularity on skin-draining LN, and of the responses to BCG was reached after 
de-worming treatment.  
An attempt to expand the lymphocyte pool was performed by frequent transfer of high numbers 
of lymphocytes to worm-infected mice, but no effect was seen on the LN cellularity from 
infected or control mice, concluding that a peripheral atrophy cannot be rescued providing 
“extra” lymphocytes. However, the lymphocyte pool was effectively expanded by 
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administration of recombinant IL-7 to worm-infected mice and helped to maintain size and 
cellularity of skin-draining LN, while the mesenteric LN did not expand more than in untreated 
worm infected mice. The function of IL-7 is of vital importance for lymphocytes development 
in the thymus and it also maintains survival and the homeostatic proliferation of naïve and 
memory T cells. Organogenesis of LN is also influenced by IL-7 232, supporting that IL-7 can 
indeed be involved in the regulation of lymphocyte pool expansion. However, a possible 
explanation of the lack of further expansion in the mLN indicates that expansion upon infection 
is also regulated.  
 
 
4.3. PAPER III: ROLE OF HIF-1 IN TUBERCULOSIS AND DIABETES 
COMORBIDITY 
 
Questions 
 
¨ Is there a role of HIF in murine diabetes-tuberculosis comorbidity? 
 
Main findings 
 
Susceptibility to tuberculosis infection is increased in obese/diabetic mice. Bacterial load in 
lungs from db/db mice were enhanced as compared to C57BL/6 controls when measured 12 
weeks after Mtb infection. 
 
HIF-1α-mediated responses were augmented during Mtb infection and diminished under 
hyperglycemia in BMM and in db/db Mtb-infected mice.  
Particularly, hif1a and HIF-1α-regulated responses were accumulated in mycobacteria-infected 
BMM. Moreover, reduced levels of HIF-1α-regulated responses were found in Mtb and BCG- 
infected BMM under high glucose conditions.  
 
Deferoxamine (DFO) a HIF chemical stabilizer, recovered impaired HIF-1 mediated responses 
in hyperglycemic conditions in vitro and reduced bacterial load in Mtb infected C57Bl/6 mice; 
hif1a and HIF-1α-regulated responses in mycobacteria-infected BMM were enhanced by DFO 
treatment. Moreover, when DFO was administrated in Mtb infected C57Bl/6 controls, the 
levels of HIF-1α-regulated lung transcripts increased, and a reduced bacterial load was found. 
 
Using HIF-1 hif1afl/fl lysm cre BMM, the role of HIF-1α in the responses of metabolic and 
immune genes during mycobacterial-infection of BMM was shown. An opposite effect was 
shown in vhlfl/fl lysm cre BMM, a strain were HIF-1α is stabilized. 
 
Discussion 
 
Here we hypothesized that an impairment of HIF-1α-regulated immune and metabolic 
responses underlie TB-DM comorbidity. 
A reduction of HIF-1α-dependent immune and metabolic responses in hyperglycemic 
conditions was observed in BMM. Moreover, BMM incubated in high glucose conditions 
showed a diminished control of the intracellular growth of Mtb.  
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We also found increased bacterial load in a Mtb-infected diabetic murine model (db/db) when 
compared to non-diabetic controls. Previous data in other diabetic and obese models, like 
streptozotocin-induced diabetic models, ob/ob and sucrose-fed guinea pigs were reported as 
susceptible to Mtb infection 233,234. HIF-1α-mediated responses in the lung were diminished in 
db/db as compared to WT mice. In contrast, our unpublished results in pre-diabetic HFD-fed 
mice with moderate hyperglycemia showed no increase in Mtb loads after 12 weeks of 
infection.  
Perhaps the more explored explanation so far, is the negative effect of reactive oxygen species 
(ROS) trough MGO generated by glycation of HIF-1α or co-activator molecules 197.  Several 
studies have shown that glycated albumin and methylglyoxal (a glycation intermediary) 
decrease the biological responses triggered when insulin binds to its receptor on the target cell. 
The molecular mechanisms that result in hampering HIF-1 functions remain to be studied.  
To demonstrate the role of HIF-1α in the reduced BMM responses during hyperglycemia, 
BMM with a conditional genomic deletion of HIF-1α and VHL in myeloid cells were used. 
We observed that in contrast to WT BMM, vhlfl/fl lysm cre BMM showed unimpaired HIF-1α-
dependent responses to mycobacterial infection in hyperglycemic as compared to euglycemic 
conditions.  
In contrast hif1afl/fl lysm cre BMM showed dramatically diminished metabolic and immune 
responses to infection with mycobacteria. Therefore, HIF-1α is central for the activation of the 
glycolytic pathway during the classical activation of macrophages. The control of intracellular 
Mtb infection was diminished in presence of hyperglycemia and was recovered in VHL-
deficient BMM even in presence of high glucose concentrations.   
Hif-1α hydroxylation can also be blocked by chemical inhibition of PHD and, as a result, 
stabilize HIF-1α. Deferoxamine (DFO) is an iron-chelator that binds free iron in a stable 
complex, preventing it from engaging in chemical reactions. PHD2 require Fe++ as a cofactor 
and thereby it is inactivated by DFO. DFO is thus a HIF-1α stabilizer. However, DFO is used   
to  treat iron intoxication  in transfusion patients 235 and more recently to reverse the negative 
effect of hyperglycemia in wound healing during  DM 236 in experimental models and patients 
237.  DFO could increase neovascularization and accelerate healing in these models. In relation, 
iron storage in the body has been reported to be associated with fat accumulation and type 2 
DM. The excess iron causes oxidative stress through production of highly toxic oxygen radicals 
via the Fenton/Haber-Weiss reaction. As mentioned above, the increase production of reactive 
oxygen species is associated with the pathophysiology of DM. Thus, DFO might act at different 
levels to restore the altered HIF-1α responses during hyperglycemia by impairing PHD 
activation or by reducing glycation of HIF-1α or co-activator molecules.  Based on these 
reasons and similar studies, DFO was selected as a HIF-1α stabilizer in this study. 
 
An effective response of BMM or mice with DFO in vitro was found. HIF-1α and HIF-1α-
regulated immune and metabolic responses associated to the activation of the glycolytic 
pathway and the activation of macrophage oxidative burst was enhanced by incubation of 
mycobacteria infected BMM treatment with DFO. Therefore, DFO was tested in vivo. A clear 
effect was evident after DFO administration in Mtb infected C57BL/6 controls, the levels of 
HIF-1α-regulated lung transcripts increased, and a reduced bacterial load was found. To 
explore the hypothesised effect of hyperglycemia and DFO, Mtb-infected diabetic mice were 
also DFO treated, but despite bacterial reduction in lungs was observed it did not reach 
significant levels (Mann Whitney test p=0,06) as compared to diabetic untreated controls. The 
 40 
db/db mice showed hyperglycemia, reaching very high blood glucose concentrations that were 
maintained without significant fluctuations for three months. However, it is important to 
indicate that the db/db mice (as described in detail in methods section) also encompasses an 
array of altered metabolic and inflammatory responses that could diminish the effect of DFO. 
Taken these results together, we propose that and increased HIF-1α function can improve 
control of infection with Mtb during DM, as schematically explained in Figure 7. 
 
 
 
 
Figure 7. HIF-1α has a protective role in Mtb infection that is affected under hyperglycemic conditions leading 
to higher Mtb infection. This effect is recovered with Deferoxamine (DFO), a HIF-1α stabilizer, further 
controlling Mtb infection in macrophages. 
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 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
In summary, all the studies here presented, although a bit diverse, had a connective line which 
is the interaction between nutrition, infections and immune responses. 
Here, the findings of these studies and their contribution to understand this interaction will be 
pointed and future perspectives briefly discussed. 
The prevalence of overweight and obesity found in the Bolivian lowlands is a reminder of the 
importance of an increasing and challenging global health problem of this century. Moreover, 
the fact that the studied population were school children is even of higher concern. On the other 
hand, the described prevalence of undernourishment, stunting, anemia and an important 
deficiency in vitamin D, alerts about the persistency of health situations that were thought to 
be already solved, or at least decreased. The knowledge of a collective heath problem helps the 
authorities of a community to, first be aware of the possible consequences, and second, to start 
improving nutritional and sanitary conditions with a major input on education. Intestinal 
parasitic infections are usually current in rural and semi-urban settings, as it was confirmed by 
showing an important prevalence. However, a correlation of infected children and nutritional 
deficiencies was not found. It is important to point out that this was a cross-sectional study, 
describing a “specific point time” situation. Therefore, a longitudinal study might be an 
improved setting in future. Moreover, an enlargement of the sample population and the addition 
of other communities with the same geographic situation could also improve the findings and 
comparisons for further analysis.  
Immune responses were then explored in an effective murine model of intestinal helminth 
infection. The findings of the second study provided experimental marks about the immune 
modulation of helminth infections and their influence on secondary infections both 
systemically and skin-localized. Moreover, evidence of atrophic distal lymph nodes and 
accumulation of naïve lymphocytes into the draining lymph node showed a dynamic 
redistribution of the lymphocyte pool. 
Finally, the startling finding of obesity and strong link with diabetes, together with an 
increasing incidence of TB-DM co-morbidity, inspired the third study. Furthermore, the 
interest of understanding possible involved mechanisms that could modulate metabolic and 
immune responses in both diseases, reinforced this idea. On this line, previous evidence about 
a possible role of HIF-1α in both tuberculosis and diabetes seemed interesting to explore. The 
findings of TB susceptibility in diabetic mice supports the importance of TB-DM comorbidity. 
Moreover, evidence of a possible protective role of HIF-1α linked to important immune and 
metabolic responses in TB and its impairment under hyperglycemic conditions, shows HIF-1α 
as an important transcription factor to focus for deeper understanding of underlaying 
mechanisms in TB-DM. Moreover, the effect of DFO as a HIF-1α stabilizer that recovered 
these protective responses in vivo, as well as under hyperglycemic conditions in vitro, is of 
relevance because it supports further studies of HIF-1α as a target and DFO as a therapeutic 
option.  
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